Kevin
Foskett, Ph.D.
Professor, Dept of Physiology
B39 Anatomy-Chemistry Bldg./6085
215-898-1354 (fax 215-573-6808)
email: foskett@mail.med.upenn.edu
http://www.med.upenn.edu/camb/faculty/cbp/foskett.html
http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=PureSearch&db=PubMed&details_term=Foskett JK
Click here for selected publications since Dr. Foskett's arrival at Penn
RESEARCH INTERESTSMolecular physiology of the inositol trisphosphate receptor
calcium release channel and the cystic fibrosis chloride channel.
RESEARCH TECHNIQUES
Molecular, biochemical and biophysical characterization of ion channels
and associated interacting proteins: cloning and mutagenesis; recombinant
protein purification; chromatography; bacterial, insect, frog and mammalian
cell expression; yeast two-hybrid screens; patch clamp electrophysiology
of single channels in native intracellular membranes; two-electrode and
transepithelial voltage clamp; confocal fluorescence
RESEARCH SUMMARY
Our laboratory is interested in calcium signaling mediated by the inositol trisphosphate (IP3) pathway, a system that becomes engaged by a wide variety of cellular stimuli. At the heart of this ubiquitous system is the IP3 receptor, a calcium ion channel localized in the endoplasmic reticulum. Mutation of this channel in animal models causes neurological defects, including epilepsy; and alterations of this pathway have been associated with Alzheimer's Disease, programmed cell death and viral infection. We use novel electrophysiological methods we developed to study the gating and regulation and structural features of native and recombinant IP3 receptor channels. Because calcium signals are highly localized in both space and time, we are engaged in discovering proteins that interact with this channel, because association of the channel in protein complexes may provide a mechanism to ensure spatial, temporal and target specificity in calcium signaling. We recently discovered interactions of the channel with proteins that regulate cell death (bcl-2 proteins) and are involved in Alzheimer's Disease (presenilins). The biophysical and cell biological aspects of these are current foci in the lab. |